Renal Oncocytoma: Preoperative Diagnosis Using Technetium 99m Sestamibi Imaging
Authors
Affiliations
Objectives: To determine if 99mTc-sestamibi (technetium 99m-methoxyisobutylisonitrile) can be used preoperatively to differentiate renal oncocytomas from other renal masses.
Methods: We performed 99mTc-sestamibi scans on 6 patients with various renal masses, using a standard technique. The diagnosis in each patient was determined either by radiologic methods.
Results: There was significantly increased uptake in the patient with the renal oncocytoma, whereas the other lesions had decreased uptake in comparison to normal kidney. This was determined visually and by mean pixel analysis.
Conclusions: Technetium 99m sestamibi scanning appears to have a potential role in the nonoperative diagnosis of renal oncocytomas, in combination with pathologic fine-needle biopsy confirmation. More definitive pathologic experience is required before recommending standard use.
Radiogenomics in Renal Cancer Management-Current Evidence and Future Prospects.
Ferro M, Musi G, Marchioni M, Maggi M, Veccia A, Del Giudice F Int J Mol Sci. 2023; 24(5).
PMID: 36902045 PMC: 10003020. DOI: 10.3390/ijms24054615.
A review of 99mTc-sestamibi SPECT/CT for renal oncocytomas: A modified diagnostic algorithm.
Wilson M, Katlariwala P, Abele J, Low G Intractable Rare Dis Res. 2022; 11(2):46-51.
PMID: 35702579 PMC: 9161129. DOI: 10.5582/irdr.2022.01027.
Ali Deb A, Agag A, Naushad N, Krishnamoorthy R, Serag H Curr Urol. 2022; 16(1):32-37.
PMID: 35633856 PMC: 9132183. DOI: 10.1097/CU9.0000000000000089.
Renal Oncocytoma: The Diagnostic Challenge to Unmask the Double of Renal Cancer.
Trevisani F, Floris M, Minnei R, Cinque A Int J Mol Sci. 2022; 23(5).
PMID: 35269747 PMC: 8910282. DOI: 10.3390/ijms23052603.
Urso L, Castello A, Rocca G, Lancia F, Panareo S, Cittanti C J Cancer Res Clin Oncol. 2022; 148(6):1299-1311.
PMID: 35217902 PMC: 9114025. DOI: 10.1007/s00432-022-03958-7.